A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
Titel:
A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
Auteur:
Tolcher, Anthony W. Rodrigueza, Wendi V. Rasco, Drew W. Patnaik, Amita Papadopoulos, Kyriakos P. Amaya, Alex Moore, Timothy D. Gaylor, Shari K. Bisgaier, Charles L. Sooch, Mina P. Woolliscroft, Michael J. Messmann, Richard A.